Investigation on the mode of action of the cytotoxic hexitols. 3. Pharmacobiochemical studies with Degranol.
D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D002247:Carbon Isotopes; D003545:Cysteine / Q000008:administration & dosage; D004273:DNA, Neoplasm / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007930:Leucine / Q000378:metabolism; D008223:Lymphoma / Q000378:metabolism; D008357:Mannomustine / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology / Q000633:toxicity; D051379:Mice; D009368:Neoplasm Transplantation; D009963:Orotic Acid / Q000378:metabolism; D051381:Rats; D012510:Sarcoma 180 / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000378:metabolism*; D012517:Sarcoma, Yoshida / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism
D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D009963:Orotic Acid; D008357:Mannomustine; D007930:Leucine; D003545:Cysteine; D013936:Thymidine